Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung
Clinical trial NCT02485652 · TERMINATED
Trial details
- NCT number
- NCT02485652
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-31
- Primary completion
- 2020-12-08
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.